搜尋結果
UFC 302 Results: Winners And Losers From Makhachev Vs. Poirier Card
Forbes· 7 日前UFC 302 Results: Everything you need to know about tonight's Islam Makhachev vs, Dustin ...
What To Know About Personalized mRNA Cancer Vaccines After Promising Trials From Moderna And Merck
Forbes· 4 日前Cancer vaccines are finally showing promise as Moderna and Merck touted promising data on an ...
Rapper BIA Accuses Cardi B Of Cheating On Husband Offset In Diss Track: What To Know About ...
Forbes· 5 日前In a season increasingly defined by high-profile rap feuds, rapper BIA released her diss track ...
Chinese cell therapy may treat asthma long term with a single jab: study
South China Morning Post· 6 日前Cytokines are signalling proteins that help control inflammation in the body, but too many ...
‘Democracy Discount’ In Indian Movie Theaters
Forbes· 2 日前RS Durai Senthilkumar’s Tamil film Garudan has managed to score $3 million in five days at the ...
Seasonal flu jabs hit record high
news.gov.hk· 5 日前The Department of Health today said over 1.86 million doses of the seasonal influenza vaccination (SIV) were administered ...
British sandwich chain Pret abandons plan to open in Israel
Reuters· 4 日前The retailer, owned by investment firm JAB and founder Sinclair Beecham, signed an agreement ...
Opinion | An Asian serial killer shows up in the UK, and gets the country buzzing
South China Morning Post· 7 日前This scary-looking member of the wasp family is at home in Hong Kong and other parts of ...
加科思(01167)以口頭報告形式在ASCO大會上公布兩項臨床數據
infocast via Yahoo財經香港· 5 日前Glecirasib與JAB-3312聯合用藥目前已在中國啟動KRAS G12C突變的一線非小細胞肺癌臨床三期試驗。Glecirasib單藥用於KRAS G12C突變二線非小細胞肺癌的新藥上 ...
加科思(01167.HK)在ASCO大會口頭報告兩項臨床數據
AASTOCKS via Yahoo財經香港· 5 日前從有效性數據來看,一線非小細胞肺癌患者共入組102例,分佈在7個劑量組,確認客觀緩解率為64.7%,疾病控制率為93.1%;從安全性資料來看,在194例患者中,三 ...